Compare Cytokinetics Inc (CYTK) vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF (QDTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $39.73. The key difference: Cytokinetics Inc is trading nearer its 52-week high, YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| CYTK | QDTY | |
|---|---|---|
Market Cap | $10.63B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $87.26 | $46.71 |
52-Week Low | $34.31 | $36.57 |
Enterprise Value | $10.74B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF
QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.
Read more on QDTY →
